Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort.
Ivell R, Heng K, Severn K, Antonio L, Bartfai G, Casanueva FF, Huhtaniemi IT, Giwercman A, Maggi M, O'Connor DB, O'Neill TW, Punab M, Rastrelli G, Slowikowska-Hilczer J, Tournoy J, Vanderschueren D, Wu FCW, Anand-Ivell R. Ivell R, et al. Among authors: wu fcw. Front Endocrinol (Lausanne). 2022 Nov 8;13:1016107. doi: 10.3389/fendo.2022.1016107. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36425465 Free PMC article.
Patterns of pulsatile luteinizing hormone and follicle-stimulating hormone secretion in prepubertal (midchildhood) boys and girls and patients with idiopathic hypogonadotropic hypogonadism (Kallmann's syndrome): a study using an ultrasensitive time-resolved immunofluorometric assay.
Wu FC, Butler GE, Kelnar CJ, Stirling HF, Huhtaniemi I. Wu FC, et al. J Clin Endocrinol Metab. 1991 Jun;72(6):1229-37. doi: 10.1210/jcem-72-6-1229. J Clin Endocrinol Metab. 1991. PMID: 1902843
Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.
Bouloux PM, Nieschlag E, Burger HG, Skakkebaek NE, Wu FC, Handelsman DJ, Baker GH, Ochsenkuehn R, Syska A, McLachlan RI, Giwercman A, Conway AJ, Turner L, van Kuijk JH, Voortman G. Bouloux PM, et al. J Androl. 2003 Jul-Aug;24(4):604-11. doi: 10.1002/j.1939-4640.2003.tb02712.x. J Androl. 2003. PMID: 12826700 Free article. Clinical Trial.
A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception.
Hay CJ, Brady BM, Zitzmann M, Osmanagaoglu K, Pollanen P, Apter D, Wu FC, Anderson RA, Nieschlag E, Devroey P, Huhtaniemi I, Kersemaekers WM. Hay CJ, et al. J Clin Endocrinol Metab. 2005 Apr;90(4):2042-9. doi: 10.1210/jc.2004-0895. Epub 2005 Jan 25. J Clin Endocrinol Metab. 2005. PMID: 15671109 Clinical Trial.
205 results